ML-193
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-110125-5MG | 5 mg | 122,00 | Add | |
| HY-110125-10MG | 10 mg | 191,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
ML-193 (CID 1261822) is a potent and selective antagonist of GPR55, with an IC50 of 221 nM. ML-193 shows more than 27-fold selectivity for GPR55 over GPR35, CB1 and CB2. ML-193 can improve the motor and the sensorimotor deficits of Parkinson’s disease (PD) rats[1][2][3].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Neurological Disease, GPCR/G Protein,Neuronal Signaling |
| Format | Solubility: DMSO : 33.33 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.82% |
| Molecular Formula | C28H25N5O4S |
| Molecular Weight | 527.59 |
| CAS-Number | 713121-80-3 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
